Skip to main content

Advertisement

Log in

Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients?

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Introduction

Acromegaly is a rare but potentially life-threatening disease, if not promptly managed, for the systemic complications due to the GH/IGF-I hypersecretion. According to the increased population life span, the number of older acromegaly patients is growing. We aim to investigate clinical features of elderly acromegaly (elderly-ACRO) and to identify the risk factors for the occurrence of comorbidities in elderly-ACRO.

Materials and methods

A retrospective and multi-center study was performed on acromegaly patients. Acromegaly comorbidities were compared among elderly-ACRO (>65 years), young acromegaly patients (young-ACRO if ≤65 years) and a control group of age and gender-matched subjects.

Result

Fifty of the 189 enrolled patients were elderly-ACRO (26.5%). Cardiovascular, metabolic, neurological/psychiatric and joint/articular disorders, nodular thyroid disease, sleep apnoea syndrome and skeletal fragility occurred more frequently in elderly-ACRO as compared to controls. Cardiovascular and metabolic disorders, nodular thyroid disease occurred significantly more frequently in elderly-ACRO as compared to young-ACRO and controls. On the other hand, neurological/psychiatric, joint/articular disorders and bone fragility occur with a similar frequency among elderly and young-ACRO. We found that elderly-ACRO had an increased risk for the occurrence of systemic arterial hypertension (p < 0.001, OR: 5.4 95%IC:2.6–10.9), left ventricular hypertrophy (p = 0.01, OR: 3 95%IC: 1.5–5.8) and metabolic disorders (p = 0.006, OR: 4.1 95%IC: 2–8.3).

Conclusion

Our results may suggest that some acromegaly comorbidities may be predominantly due to acromegaly “per-se” rather than to aging. On the contrary, cardiovascular and metabolic disorders seem to be due to aging as well.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. L. Katznelson, E.R. Laws, S. Melmed, M.E. Molitch, M.H. Murad, A. Utz et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–3951 (2014)

    Article  CAS  PubMed  Google Scholar 

  2. A. Colao, L.F.S. Grasso, A. Giustina, S. Melmed, P. Chanson, A.M. Pereira et al. Acromegaly. Nat. Rev. Dis. Prim. 5(1), 20 (2019)

    Article  PubMed  Google Scholar 

  3. M.R. Ambrosio, I. Gagliardi, S. Chiloiro, A.G. Ferreira, M. Bondanelli, A. Giampietro, A. Bianchi, L. Marinis, M. Fleseriu, M.C. Zatelli, Acromegaly in the elderly patients. Endocrine 68(1), 16–31 (2020). https://doi.org/10.1007/s12020-020-02206-7

    Article  CAS  PubMed  Google Scholar 

  4. A. Colao, R. Pivonello, L. Spinelli, M. Galderisi, R. Auriemma, M. Galdiero et al. A retrospective analysis on bio-chemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients. J. Endocrinol. Invest 30(6), 497–506 (2007)

    Article  CAS  PubMed  Google Scholar 

  5. J.D. Nabarro, Acromegaly. Clin. Endocrinol. 26, 481–512 (1987)

  6. G. Minniti, V. Esposito, M. Piccirilli, A. Fratticci, A. Santoro, M.L. Jaffrain-Rea, Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur. J. Endocrinol. 153(6), 723–735 (2005)

    Article  CAS  PubMed  Google Scholar 

  7. P.K. Whelton, R.M. Carey, W.S. Aronow, D.E. Casey Jr, K.J. Collins, C. Dennison Himmelfarb, S.M. DePalma, S. Gidding, K.A. Jamerson, D.W. Jones, E.J. MacLaughlin, P. Muntner, B. Ovbiagele, S.C. Smith Jr, C.C. Spencer, R.S. Stafford, S.J. Taler, R.J. Thomas, K.A. Williams Sr, J.D. Williamson, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71(6), e13 (2018)

    CAS  PubMed  Google Scholar 

  8. L.M. Fatti, B. Cangiano, G. Vitale, L. Persani, G. Mantovani, E. Sala, M. Arosio, P. Maffei, F. Dassie, M. Mormando, A. Giampietro, L. Tanda, E.R. Masiello, E. Nazzari, D. Ferone, S. Corbetta, E. Passeri, F. Guaraldi, S. Grottoli, S. Cannavò, M.L.T. Torre, D. Soranna, A. Zambon, F. Cavagnini, M. Scacchi; Study Group on Motor Disability in Acromegaly of the Italian Society of Endocrinology, Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity. Pituitary 22(5), 552–560 (2019). https://doi.org/10.1007/s11102-019-00966-8

    Article  CAS  PubMed  Google Scholar 

  9. A. Giustina, G. Barkhoudarian, A. Beckers, A. Ben-Shlomo, N. Biermasz, B. Biller, et al. Multidisciplinary management of acromegaly: A consensus. Rev. Endocr. Metab. Disord. 2020; https://doi.org/10.1007/s11154-020-09588-z

  10. S. Melmed, M.D. Bronstein, P. Chanson, A. Klibanski, F.F. Casanuela, J.A.H. Wass, C.J. Strasburger, A. Luger, D.R. Clemmons, A. Giustina, A Consensus Statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14(9), 552–561 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  11. A.M. Ramos-Leví, M. Marazuela. Bringing cardiovascular comorbidities in acromegaly to an update. How should we diagnose and manage them? Front. Endocrinol. 10, 120 (2019)

  12. A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25(1), 102–152 (2004)

    Article  CAS  PubMed  Google Scholar 

  13. L. Maione, T. Brue, A. Beckers, B. Delemer, P. Petrossians, F. Borson-Chazot et al. Changes in the management and comorbidities of acromegaly over three decades: the French acromegaly registry. Eur. J. Endocrinol. 176(5), 645–655 (2017)

    Article  CAS  PubMed  Google Scholar 

  14. S. Fieffe, I. Morange, P. Petrossians, P. Chanson, V. Rohmer, C. Cortet et al. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French acromegaly registry. Eur. J. Endocrinol. 164(6), 877–884 (2011)

    Article  CAS  PubMed  Google Scholar 

  15. A.V. Dreval, I.V. Trigolosova, I.V. Misnikova, Y.A. Kovalyova, R.S. Tishenina, I.A. Barsukov et al. Prevalence of diabetes mellitus in patients with acromegaly. Endocr. Connect. 3(2), 93–98 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. H. Biering, G. Knappe, H. Gerl, H. Lochs, Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Austriaca 27(1), 27–31 (2000)

    Article  CAS  PubMed  Google Scholar 

  17. O. Alexopoulou, M. Bex, P. Kamenicky, A.B. Mvoula, P. Chanson, D. Maiter, Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary 17(1), 81–89 (2014)

    Article  CAS  PubMed  Google Scholar 

  18. J.M. Silverstein, E.D. Roe, K.M. Munir, J.L. Fox, B. Emir, M. Kouznetsova et al. Use of electronic health records to characterize a rare disease in the u.s.: treatment, comorbidities, and follow-up trends among patients with a confirmed diagnosis of acromegaly. Endocr. Pract. 24(6), 517–526 (2018)

    Article  PubMed  Google Scholar 

  19. J. Dal, U. Feldt-Rasmussen, M. Andersen, L. Kristensen, P. Laurberg, L. Pedersen et al. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur. J. Endocrinol. 175(3), 181–190 (2016)

    Article  CAS  PubMed  Google Scholar 

  20. A.L. Espinosa-de-los-Monteros, B. González, G. Vargas, E. Sosa, M. Mercado, Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism. Pituitary 14(3), 231–235 (2011)

    Article  CAS  PubMed  Google Scholar 

  21. M.R. Gadelha, L. Kasuki, D.S.T. Lim, M. Fleseriu, Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr. Rev. 40(1), 268–332 (2019)

    Article  PubMed  Google Scholar 

  22. K.M.J.A. Claessen, A.N. Canete, P.W. de Bruin, A.M. Pereira, M. Kloppenburg, H.M. Kroon et al. Acromegalic arthropathy in various stages of the disease: an MRI study. Eur. J. Endocrinol. 176(6), 779–790 (2017)

    Article  CAS  PubMed  Google Scholar 

  23. G. Mazziotti, F. Maffezzoni, S. Frara, A. Giustina, Acromegalic osteopathy. Pituitary 20(1), 63–69 (2017)

    Article  CAS  PubMed  Google Scholar 

  24. B. Cangiano, E. Giusti, C. Premoli, D. Soranna., G. Vitale, S. Grottoli, et al. “PRO-ACRO” study group on Motor Disability in Acromegaly, of the Italian Society of Endocrinology (SIE). Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life. Endocrine. 2022. https://doi.org/10.1007/s12020-022-03106-8

  25. L.L. Kropf, M. Madeira, L. Vieira Neto, M.R. Gadelha, M.L.F. de Farias, Functional evaluation of the joints in acromegalic patients and associated factors. Clin. Rheumatol. 32(7), 991–998 (2013)

    Article  PubMed  Google Scholar 

  26. N.R. Biermasz, M.J.E. Wassenaar, A.A. van der Klaauw, A.M. Pereira, J.W.A. Smit, F. Roelfsema et al. Pretreatment insulin- like growth factor-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured dis- ease. J. Clin. Endocrinol. Metab. 94(7), 2374–2379 (2009)

    Article  CAS  PubMed  Google Scholar 

  27. I. Gagliardi, S. Chiloiro, M. Vallillo, M. Bondanelli, S. Volpato, A. Giampietro, A. Bianchi, L. De Marinis, M.C. Zatelli, M.R. Ambrosio, Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study. BMC Geriatr. 21(1), 598 (2021). https://doi.org/10.1186/s12877-021-02549-4

    Article  PubMed  PubMed Central  Google Scholar 

  28. A. Giustina, F.F. Casanueva, F. Cavagnini, P. Chanson, D. Clemmons, L.A. Frohman, R. Gaillard, K. Ho, P. Jaqut, D.L. Kleinberg, S.W.J. Lamberts, G. Lombardi, M. Sheppard, C.J. Sreasburger, M.L. Vance, J.A.H. Wass, S. Melmed, Diagnosis and treatment of acromegaly complications. J. Endocrinol. Invest 26, 1242–1247 (2003)

    Article  CAS  PubMed  Google Scholar 

  29. M. Fleseriu, B.M.K. Biller, P.U. Freda, M.R. Gadelha, A. Giustina, L. Katznelson, M.E. Molitch, S.L. Samson, C.J. Strasburger, A.J. van der Lely, S. Melmed, A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1), 1–13 (2021). https://doi.org/10.1007/s11102-020-01091-7.

    Article  PubMed  Google Scholar 

  30. P. Petrossians, A.F. Daly, E. Natchev, L. Maione, K. Blijdorp, M. Sahnoun-Fathallah et al. Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) database. Endocr. Relat. Cancer 24(10), 505–518 (2017)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. A. Ribeiro-Oliveira, M.M. Abrantes, A.L. Barkan, Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with acromegaly: further evidence for a present hypothalamic control of pituitary somatotropinomas. J. Clin. Endocrinol. Metab. 98(7), 2959–2966 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. D. Cuevas-Ramos, J.D. Carmichael, O. Cooper, V.S. Bonert, A. Gertych, A.N. Mamelak et al. A structural and functional acromegaly classification. J. Clin. Endocrinol. Metab. 100(1), 122–131 (2015)

    Article  CAS  PubMed  Google Scholar 

  33. S. Chiloiro, A. Bianchi, A. Giampietro, L. De Marinis (2019) Somatotropic Axis in Human Aging. In: Ilpo Huhtaniemi and Luciano Martini, (Eds.), Encyclopedia of Endocrine Diseases, Second Edition, vol. 1, pp. 700–707. Oxford: Academic Press. https://doi.org/10.1016/B978-0-12-812199-3.66167-4

  34. A.M. Arafat, M. Möhlig, M.O. Weickert, F.H. Perschel, J. Purschwitz, J. Spranger et al. Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J. Clin. Endocrinol. Metab. 93(4), 1254–1262 (2008)

    Article  CAS  PubMed  Google Scholar 

  35. E.C. degli Uberti, M.R. Ambrosio, S.G. Cella, A.R. Margutti, G. Trasforini, A.E. Rigamonti et al. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man. J. Clin. Endocrinol. Metab. 82(9), 2885–2888 (1997)

    CAS  PubMed  Google Scholar 

  36. D. Cuevas-Ramos, J.D. Carmichael, O. Cooper, V.S. Bonert, A. Gertych, A.N. Mamelak et al. A structural and functional acromegaly classification. J. Clin. Endocrinol. Metab. 100(1), 122–131 (2015)

    Article  CAS  PubMed  Google Scholar 

  37. K. Tanimoto, N. Hizuka, I. Fukuda, K. Takano, T. Hanafusa, The influence of age on the GH–IGF1 axis in patients with acromegaly. Eur. J. Endocrinol. 159(4), 375–379 (2008)

    Article  CAS  PubMed  Google Scholar 

  38. S. Petersenn, M. Buchfelder, B. Gerbert, H. Franz, H.J. Quabbe, H.M. Schulte et al. Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German acromegaly register. Clin. Endocrinol. 71(3), 400–405 (2009)

    Article  CAS  Google Scholar 

  39. S. Chiloiro, A. Bianchi, F. Doglietto, C. de Waure, A. Giampietro, A. Fusco, D. Iacovazzo, L. Tartaglione, F. Di Nardo, F. Signorelli, L. Lauriola, C. Anile, G. Rindi, G. Maira, A. Pontecorvi, De, L. Marinis, Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review. Pituitary 17(3), 267–276 (2014). https://doi.org/10.1007/s11102-013-0500-6.23

    Article  PubMed  Google Scholar 

  40. M. Arosio, G. Reimondo, E. Malchiodi, P. Berchialla, A. Borraccino, L. De Marinis et al. Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur. J. Endocrinol. 167(2), 189–198 (2021)

    Article  Google Scholar 

  41. M.J.A. Puchner, U.J. Knappe, D.K. Lüdecke, Pituitary surgery in elderly patients with acromegaly. Neurosurgery 36(4), 677–684 (1995)

    Article  CAS  PubMed  Google Scholar 

  42. K. Arita, H. Hirano, S. Yunoue, S. Fujio, A. Tominaga, T. Sakoguchi et al. Treatment of elderly acromegalics. Endocr. J. 55(5), 895–903 (2008)

    Article  PubMed  Google Scholar 

  43. H. Sun, J. Brzana, C.G. Yedinak, S.H. Gultekin, J.B. Delashaw, M. Fleseriu, Factors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly. J. Neurol. Surg. Part B Skull Base 75(1), 47–52 (2014)

    Article  Google Scholar 

  44. M. Taghvaei, S.M. Sadrehosseini, J. Ardakani, M. Nakhjavani, M. Zeinalizadeh, Endoscopic endonasal approach to the growth hormone-secreting pituitary adenomas: endocrinologic outcome in 68 patients. World Neurosurg. 11, e259–e268 (2018)

    Article  Google Scholar 

  45. A. Spina, M. Losa, P. Mortini, Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series. Endocrine 65(3), 637–645 (2019)

    Article  CAS  PubMed  Google Scholar 

  46. Y. Sasagawa, Y. Hayashi, O. Tachibana, A. Nakagawa, M. Oishi, T. Takamura et al. Transsphenoidal surgery for elderly patients with acromegaly and its outcomes: comparison with younger patients. World Neurosurg. 118, e229–e234 (2018)

    Article  PubMed  Google Scholar 

  47. S. Chiloiro, A. Giampietro, F. Mirra, F. Donfrancesco, T. Tartaglione, P.P. Mattogno, F. Angelini, L. Liverana, M. Gessi, A. Carmelo, G. Rindi, A. Giustina, M. Fleseriu, A. Pontecorvi, L. De Marinis, A. Bianchi, Pegvisomant and Pasireotide LAR as second-line therapy in acromegaly: clinical effectiveness and predictors of response. Eur. J. Endocrinol. 184(2), 217–229 (2021). https://doi.org/10.1530/EJE-20-0767

    Article  CAS  PubMed  Google Scholar 

  48. S. Chiloiro, A. Giampietro, A. Bianchi, T. Tartaglione, C. Bima, M.G. Vita et al. Acromegaly can be cured by first-line pasireotide treatment? Endocrine 64(1), 196–199 (2019)

    Article  CAS  PubMed  Google Scholar 

  49. S. Chiloiro, C. Bima, T. Tartaglione, A. Giampietro, M. Gessi, L. Lauretti, et al. Pasireotide and pegvisomant combination treatment in acromegaly resistant to second-line therapies: a longitudinal study. J. Clin. Endocrinol. Metab. 2019. https://doi.org/10.1210/jc.2019-00825

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura De Marinis.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethics

All procedures performed in the study were in accordance with the ethical standards of the institutional review board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by Institutional Review Board of the Gemelli Hospital, Catholic University of the Sacred Heart, Rome, and of Azienda Ospedaliera Universitaria of Ferrara.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chiloiro, S., Giampietro, A., Gagliardi, I. et al. Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients?. Endocrine 80, 142–151 (2023). https://doi.org/10.1007/s12020-022-03261-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-022-03261-y

Keywords

Navigation